# CEPI

leads the 100 Days Mission, a coordinated framework to compress the pathogen-to-authorized-vaccine timeline, publishing rapid-response manufacturing frameworks and emergency clinical- research principles with academic and industry partners.


Source: https://en.bioecon.ru/companies/cepi/
Updated: 2026-08-15

- Country: Norway

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Affiliation | Coalition for Epidemic Preparedness Innovations (CEPI) | https://pmc.ncbi.nlm.nih.gov/articles/PMC12389860/, https://static.cepi.net/downloads/2023-12/Programme-Document_April-2019.pdf, https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf, https://static.cepi.net/downloads/2025-09/CEPI-Backgrounder_Aug-2025.pdf |
| Research focus | 100 Days Mission to accelerate vaccine development, rapid-response manufacturing frameworks, and vaccine platforms for epidemic/pandemic pathogens | https://cepi.net/100-days-mission, https://pmc.ncbi.nlm.nih.gov/articles/PMC12389860/, https://static.cepi.net/downloads/2023-12/Programme-Document_April-2019.pdf, https://static.cepi.net/downloads/2025-09/CEPI-Backgrounder_Aug-2025.pdf, https://static.cepi.net/downloads/2026-02/CEPI%203.0%20Strategy%20Report%20DIG%20ENG%20FINAL.pdf |
| Facility | Centralised Laboratory Network, Preclinical Model Network, and Vaccine Manufacturing Facility Network | https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf, https://static.cepi.net/downloads/2026-02/CEPI%203.0%20Strategy%20Report%20DIG%20ENG%20FINAL.pdf |
| Grant | Invests in global R&D and manufacturing partnerships, including vaccine candidates, platforms, and enabling science projects | https://cepi.net/100-days, https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf, https://static.cepi.net/downloads/2026-02/CEPI%203.0%20Strategy%20Report%20DIG%20ENG%20FINAL.pdf |
| Publications | Strategic reports, annual accounts, board reports, and technical vaccine development/manufacturing frameworks | https://pmc.ncbi.nlm.nih.gov/articles/PMC12389860/, https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf, https://static.cepi.net/downloads/2026-02/CEPI%203.0%20Strategy%20Report%20DIG%20ENG%20FINAL.pdf |
| Principal staff | Richard Hatchett (CEO), Nicole Lurie (Executive Director Emergency Response), and various functional Executive Directors | https://cepi.net/cepi-board, https://pmc.ncbi.nlm.nih.gov/articles/PMC12389860/, https://static.cepi.net/downloads/2023-12/Programme-Document_April-2019.pdf, https://static.cepi.net/downloads/2024-08/CEPI%20B26%2001.01%20March%202024%20minutes%20FINAL.pdf |
| Headcount | 330 employees (as of 31 December 2024) | https://static.cepi.net/downloads/2024-03/CEPI%20Board%20of%20Directors'%20report,%20Annual%20Accounts%20and%20Auditors%20report%202023.pdf, https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf |

Independent sources: pmc.ncbi.nlm.nih.gov

## Technologies

- [Biological emergency preparedness](https://en.bioecon.ru/technology/bio-emergency-preparedness/)